…I’m down ~11% from the first posting on 10/21/2009. Still, they have 21% insider/major holders today, and they have been doing no more than the usual selling for profit taking and some minor buying that could be PR or cautious accumulation, so I’m contemplating buying some more. My hesitation is their debt, which is OK for a bio-tech, but ripe for a share offering that would dilute the current shares. My timing has been off lately, so that would happen about 2 -3 minutes after I bought.
Have an opinion on AGEN? Post it here!
